Skip to main content
Veterinary Medicines

Baycox 2.5 % Drank

Authorised
  • Toltrazuril

Product identification

Medicine name:
Baycox 2.5 % Drank
Baycox 2.5 % Solution buvable
Baycox 2.5 % Lösung zum Einnehmen
Active substance:
  • Toltrazuril
Target species:
  • Chicken
  • Turkey
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Toltrazuril
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        14
        day
      • Egg
        no withdrawal period
    • Turkey
      • Meat and offal
        16
        day
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC01
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Baycox 5 l Bottle Oral solution
  • Baycox 1 l Bottle Oral solution
  • Baycox 100 ml Bottle Oral solution

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V142694
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 18/08/2025
French (PDF)
Published on: 18/08/2025
German (PDF)
Published on: 18/08/2025